financetom
Business
financetom
/
Business
/
Tradr ETFs launches first longer-dated 'calendar' reset leveraged ETFs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tradr ETFs launches first longer-dated 'calendar' reset leveraged ETFs
Sep 4, 2024 12:14 AM

Sept 3 (Reuters) - Tradr ETFs has rolled out a group of

eight leveraged exchange-traded funds (ETFs) designed to allow

investors and speculators to hold on to them for a week or even

a month, the company said on Tuesday.

The move is a bid to shake up the growing universe of

leveraged and inverse ETFs that allow investors to capture up to

three times the return (or loss) of an underlying index or

single stock and have attracted some $117 billion in assets,

according to Morningstar. Until now, those products have offered

users the chance to bet only the daily return of broad market

products like the SPDR S&P 500 ETF Trust or volatile,

heavily traded stocks like Nvidia ( NVDA )

"The reality is that a sizeable percentage of people who own

these actually don't close out their positions at the end of a

trading day," said Matthew Markiewicz, head of product and

capital markets at Tradr.

Hanging on to these leveraged products longer than a single

day can make investors vulnerable to so-called "volatility

drag," a phenomenon that over time can magnify gains or losses

even beyond the leverage the fund provides. That could compound

losses in a down market, as exposure is reset daily.

Tradr has launched six new index-based products offering

twice the daily returns on three major U.S. indexes, including

the S&P 500, half of which will reset weekly and the others on a

monthly basis. It also is introducing two single-stock leveraged

ETFs, one designed to capture 1.75x the weekly return of Nvidia ( NVDA )

and the other to deliver 1.5x the weekly return of Tesla

.

"There's more of an appetite for long, bullish offerings,"

Markiewicz said.

Tradr hopes the new ETFs can emerge as core portfolio

holdings, a role Markiewicz said that the current daily reset

products can't fill.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved